SCHEMBL20563458

SCHEMBL20563458

CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccccc4Cl)c(=O)n(C)c3n2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK2 O43353 10/20 1.00
NOD2 Q9HC29 10/20 1.00
ACVR1 Q04771 7/20 1.00
FGFR1 P11362 6/20 0.84
WEE1 P30291 5/20 0.84
SRC P12931 4/20 0.84
FGFR2 P21802 2/20 0.84
FGFR4 P22455 2/20 0.84
FGFR3 P22607 2/20 0.84
PDGFRB P09619 2/20 0.84
PDGFRA P16234 2/20 0.84
CHEK1 O14757 1/20 0.84
JAK2 O60674 1/20 0.84
PRKD3 O94806 1/20 0.84
MAP4K4 O95819 1/20 0.84
PAK4 O96013 1/20 0.84
ABL1 P00519 1/20 0.84
EGFR P00533 1/20 0.84
NTRK1 P04629 1/20 0.84
LCK P06239 1/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29498246 1.00 RIPK2 (1.00) RIPK2NOD2ACVR1FGFR1WEE1
Pd-0166285 SCHEMBL30250248 0.92 FGFR1 (1.00) RIPK2NOD2ACVR1FGFR1WEE1
Pd-0166285 SCHEMBL133914 0.92 FGFR1 (1.00) RIPK2NOD2ACVR1FGFR1WEE1
Pd-0166285 SCHEMBL30276696 0.91 FGFR1 (0.98) RIPK2NOD2ACVR1FGFR1WEE1
SCHEMBL20564619 0.91 RIPK2 (1.00) RIPK2NOD2ACVR1FGFR1WEE1
Pd-0166285 SCHEMBL15106017 0.91 FGFR1 (0.98) RIPK2NOD2ACVR1FGFR1WEE1
SCHEMBL29498180 0.91 RIPK2 (1.00) RIPK2NOD2ACVR1FGFR1WEE1
Pd-0166285 SCHEMBL29658286 0.90 FGFR1 (0.97) RIPK2NOD2ACVR1FGFR1WEE1
Pd-0166285 SCHEMBL15923205 0.90 FGFR1 (0.97) RIPK2NOD2ACVR1FGFR1WEE1
SCHEMBL20563994 0.89 RIPK2 (1.00) RIPK2NOD2ACVR1FGFR1WEE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624032-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases UNIVERSITY OF HOUSTON SYSTEM (US) 2026-05-12 US disclosed
US-12516055-B2 Protein kinase inhibitors and uses thereof for the treatment of diseases and conditions TRUSTEES OF TUFTS COLLEGE (US) 2026-01-06 US disclosed
EP-4480485-A2 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS University of Houston System (US) 2024-12-25 EP disclosed
US-20240327403-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES UNIVERSITY OF HOUSTON SYSTEM (US) 2024-10-03 US disclosed
EP-3968991-B1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS UNIV HOUSTON SYSTEM (US) 2024-07-31 EP disclosed
US-12012402-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases UNIVERSITY OF HOUSTON SYSTEM (US) 2024-06-18 US disclosed
US-20220194937-A1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS UNIVERSITY OF HOUSTON SYSTEM 2022-06-23 US disclosed
US-20220064163-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES UNIVERSITY OF HOUSTON SYSTEM (US) 2022-03-03 US disclosed
WO-2020232190-A1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS UNIVERSITY OF HOUSTON SYSTEM (US) 2020-11-19 WO disclosed
WO-2018213219-A1 PYRIDO[2,3-D]PYRIMIDIN-7ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES UNIVERSITY OF HOUSTON SYSTEM (US) 2018-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327403-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES RIPK2, RIPK1, RIPK4 RIPK2 1/4885NOD2 538/4885ACVR1 7/4885
US-20220064163-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES RIPK2, RIPK1, RIPK4 RIPK2 1/4885NOD2 538/4885ACVR1 7/4885
US-12012402-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases RIPK2, RIPK1, RIPK4 RIPK2 1/4885NOD2 538/4885ACVR1 7/4885
US-20220194937-A1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS RIPK2, RIPK1, RIPK4 RIPK2 1/4885NOD2 295/4885ACVR1 7/4885
US-12624032-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases RIPK2, RIPK1, RIPK4 RIPK2 1/4885NOD2 171/4885ACVR1 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.